title: Effective inhibition of HCMV UL49 gene expression and viral replication by oligonucleotide external guide sequences and RNase P.
abstract: BACKGROUND
  Human cytomegalovirus (HCMV) is a ubiquitous herpesvirus that typically causes asymptomatic infections in healthy individuals but may lead to serious complications in newborns and immunodeficient individuals. The emergence of drug-resistant strains of HCMV has posed a need for the development of new drugs and treatment strategies. Antisense molecules are promising gene-targeting agents for specific regulation of gene expression. External guide sequences (EGSs) are oligonucleotides that consist of a sequence complementary to a target mRNA and recruit intracellular RNase P for specific degradation of the target RNA. The UL49-deletion BAC of HCMV was significantly defective in growth in human foreskin fibroblasts. Therefore, UL49 gene may serve as a potential target for novel drug development to combat HCMV infection. In this study, DNA-based EGS molecules were synthesized to target the UL49 mRNA of human cytomegalovirus (HCMV).
  
  
  RESULTS
  By cleavage activity assessing in vitro, the EGS aimed to the cleavage site 324 nt downstream from the translational initiation codon of UL49 mRNA (i.e. EGS324) was confirmed be efficient to direct human RNase P to cleave the target mRNA sequence. When EGS324 was exogenously administered into HCMV-infected human foreskin fibroblasts (HFFs), a significant reduction of ~76% in the mRNA and ~80% in the protein expression of UL49 gene, comparing with the cells transfected with control EGSs. Furthermore, a reduction of about 330-fold in HCMV growth were observed in HCMV-infected HFFs treated with the EGS.
  
  
  CONCLUSIONS
  These results indicated that UL49 gene was essential for replication of HCMV. Moreover, our study provides evidence that exogenous administration of a DNA-based EGS can be used as a potential therapeutic approach for inhibiting gene expression and replication of a human virus.
authors.affiliation: National Engineering Research Center of Genetic Medicine, Jinan University, Guangzhou, China.
authors.forename: WenJun
authors.initials: W
authors.lastname: Zhang
authors.forename: HongJian
authors.initials: H
authors.lastname: Li
authors.forename: YueQin
authors.initials: Y
authors.lastname: Li
authors.forename: ZhiFeng
authors.initials: Z
authors.lastname: Zeng
authors.forename: ShiQian
authors.initials: S
authors.lastname: Li
authors.forename: Xin
authors.initials: X
authors.lastname: Zhang
authors.forename: Yi
authors.initials: Y
authors.lastname: Zou
authors.forename: TianHong
authors.initials: T
authors.lastname: Zhou
mesh_terms: D002460:Cell Line; D003587:Cytomegalovirus / Q000187:drug effects / Q000235:genetics / Q000502:physiology*; D003586:Cytomegalovirus Infections / Q000201:enzymology / Q000821:virology*; D015536:Down-Regulation / Q000187:drug effects*; D015967:Gene Expression Regulation, Viral / Q000187:drug effects*; D006801:Humans; D009841:Oligonucleotides / Q000138:chemical synthesis / Q000235:genetics / Q000494:pharmacology*; D043262:Ribonuclease P / Q000378:metabolism*; D015678:Viral Structural Proteins / Q000235:genetics* / Q000378:metabolism; D014779:Virus Replication / Q000187:drug effects*
chemical_list: D009841:Oligonucleotides; D015678:Viral Structural Proteins; D043262:Ribonuclease P